PI3K: Missense Mutation Motivates Malignancy.
Hawthorne
Valerie Stone
VS
Department Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA. vstone@mdanderson.org
Yu
Dihua
D
D014408:Biomarkers, Tumor / Q000235:genetics* / Q000378:metabolism; D001943:Breast Neoplasms / Q000201:enzymology / Q000235:genetics*; D058534:Class I Phosphatidylinositol 3-Kinases; D018450:Disease Progression; D005260:Female; D015971:Gene Expression Regulation, Enzymologic; D006801:Humans; D020125:Mutation, Missense; D019869:Phosphatidylinositol 3-Kinases / Q000235:genetics* / Q000378:metabolism
D014408:Biomarkers, Tumor; D019869:Phosphatidylinositol 3-Kinases; D058534:Class I Phosphatidylinositol 3-Kinases; C484760:PIK3CA protein, human